Featured Research

from universities, journals, and other organizations

Daily walk of just 3 km can reduce risk of hospitalization for respiratory problems

Date:
February 18, 2014
Source:
Wiley
Summary:
New research shows that suffers of Chronic obstructive pulmonary disease (COPD) can reduce their risk of being hospitalized with severe attacks, by maintaining an exercise regime of walking between three to six kilometers a day. COPD, a term which includes chronic bronchitis and emphysema, results in breathing difficulties due to long-term lung damage. Severe symptoms (eCOPD), caused by a sudden loss of lung function, can be life threatening.

New research in Respirology shows that suffers of Chronic obstructive pulmonary disease (COPD) can reduce their risk of being hospitalized with severe attacks, by maintaining an exercise regime of walking between three to six kilometers a day.

COPD, a term which includes chronic bronchitis and emphysema, results in breathing difficulties due to long-term lung damage. Severe symptoms (eCOPD), caused by a sudden loss of lung function, can be life threatening.

543 COPD patients were recruited from five Spanish respiratory clinics and their exercise levels were calculated based on the distance they walked during the course of a week. This information was compared to hospitalization data taken from the database of Bilbao's Hospital Galdakao-Usansolo.

The results showed that COPD patients who maintained moderate or high levels of exercise over time, which may amount to low intensity activities such as walking for at least three to six kilometers per day, could reduce the likelihood of being hospitalized by severe symptoms.

In contrast, patients who maintained a low level of exercise or reduced their exercise over time were more likely to experience a significant increase in the rate of hospitalization with exacerbated symptoms.

"COPD patients are less likely to engage in regular physical activity than healthy individuals. However, regular exercise has been associated with reduced risk of hospitalization for exacerbated COPD and mortality among patients with COPD," said Dr. Cristóbal Esteban. "Indeed, even a low level of PA such as walking a minimum of 2 hours per week has been associated with decreased risk of hospitalization for exacerbated COPD."


Story Source:

The above story is based on materials provided by Wiley. Note: Materials may be edited for content and length.


Journal Reference:

  1. Cristóbal Esteban, Inmaculada Arostegui, Myriam Aburto, Javier Moraza, José M. Quintana, Susana Aizpiri, Luis V. Basualdo, Alberto Capelastegui. Influence of changes in physical activity on frequency of hospitalization in chronic obstructive pulmonary disease. Respirology, 2014; DOI: 10.1111/resp.12239

Cite This Page:

Wiley. "Daily walk of just 3 km can reduce risk of hospitalization for respiratory problems." ScienceDaily. ScienceDaily, 18 February 2014. <www.sciencedaily.com/releases/2014/02/140218100711.htm>.
Wiley. (2014, February 18). Daily walk of just 3 km can reduce risk of hospitalization for respiratory problems. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2014/02/140218100711.htm
Wiley. "Daily walk of just 3 km can reduce risk of hospitalization for respiratory problems." ScienceDaily. www.sciencedaily.com/releases/2014/02/140218100711.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) — Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) — Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) — Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins